Funded Hospitals and Health Care Startups in United States
Among the 13 most recent Hospitals and Health Care entries, one disclosed round stands out: Medix Infusion raised $35M on 2023-01-09, which dwarfs the next…
Among the 13 most recent Hospitals and Health Care entries, one disclosed round stands out: Medix Infusion raised $35M on 2023-01-09, which dwarfs the next-largest disclosed amounts ($46M is present for Fathom on 2022-11-09; and the remainder cluster mostly in the low millions). Several cities also appear as clusters by geography: Ohio shows up twice (Nexus Bedside in Cleveland, 2025-03-03; and High Enroll in Cincinnati, 2022-11-15). Stage and disclosure patterns are mixed: Seed appears twice (Nexus Bedside 2025-03-03 for $3M; InpharmD 2023-12-07 for $6M), while three entries are “Series Unknown” with disclosed amounts of $2M (Sendaride, 2024-05-10), $2M (Proactive Diagnostics, 2022-11-03), and $420K (Curious Learning, 2023-12-20), plus three more entries are undisclosed (Staritas 2026-04-21; Well iQ 2022-12-21; each undisclosed). Temporally, the window runs from 2022-11-03 (Proactive Diagnostics) through 2026-04-21 (Staritas), with a notable concentration in 2022-11-09 (three different companies share the same date: Fathom, Positive Development, and, with a different series, Legion Health).
Most recent rounds
13 shownRelated listings
Frequently asked
Which disclosed round is the clear outlier in this list, and how far above the rest is it?
Fathom’s $46M round on 2022-11-09 is the largest disclosed amount in the shown rows. It sits well above other disclosed rounds such as Medix Infusion’s $35M (2023-01-09) and Positive Development’s $37M (2022-11-09).
Do the most recent entries cluster tightly by time or are they spread out?
Yes—there’s a long tail, but the latest cluster is small: only Staritas appears at 2026-04-21 (undisclosed), while the next most recent disclosed item is Nexus Bedside on 2025-03-03 ($3M). In contrast, multiple deals share the same cutoff window around 2022-11-09 (Fathom, Positive Development, and Legion Health).
Are there over-represented locations within the Hospitals and Health Care entries shown?
Ohio is represented twice: Nexus Bedside in Cleveland (2025-03-03) and High Enroll in Cincinnati (2022-11-15). California also appears multiple times (Fathom in San Francisco on 2022-11-09 and Proactive Diagnostics in Thousand Oaks on 2022-11-03; both are in the 2022-11 edge of the dataset).
How does the stage mix look when you focus on disclosed amounts rather than “undisclosed/unknown”?
Seed rounds with disclosed amounts include Nexus Bedside ($3M on 2025-03-03) and InpharmD ($6M on 2023-12-07). Series B shows up with higher disclosed amounts such as Medix Infusion ($35M on 2023-01-09) and Fathom ($46M on 2022-11-09), suggesting materially larger disclosed checks than the Seed entries in these rows.
Is disclosure itself an outlier—do many companies report undisclosed amounts or “Series Unknown”?
Three entries are undisclosed on amount: Staritas (2026-04-21), Well iQ (2022-12-21), and each appears without a dollar figure in the shown rows. Separately, “Series Unknown” appears frequently (e.g., Bluem Nursing on 2024-05-10 with $120K; Sendaride on 2024-05-10 with $2M; and Proactive Diagnostics on 2022-11-03 with $2M).
Which specific cities or companies are worth a closer look because they combine higher amounts with tighter date proximity?
The strongest proximity signal is 2022-11-09: Fathom raised $46M (San Francisco), Positive Development raised $37M (Washington, District of Columbia), and Legion Health raised $4M (Carrollton, Texas). That same-date grouping contrasts with the $2M rounds on 2024-05-10 (Sendaride in Oklahoma City and Bluem Nursing’s $120K nearby, also on 2024-05-10), indicating different funding “bands” over time.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.